FDA-approved device detects diabetic neuropathy via sweatglands

A new FDA-approved device detects diabetic neuropathy via sweatglands, according to an announcement from the American Association of Clinical Endocrinologists about new research. The method "identifies sweat dysfunction in the hands and feet by measuring the skin conductance response through the sweat glands," also helping to diagnose what type of diabetic neuropathy one has.

"The new method requires no special skills and has a sensitivity of 80 percent and specificity of 90 percent for diagnosing peripheral neuropathy," said Aaron Vinik, M.D., director of research and the euroendocrine unit at Eastern Virginia Medical School, who presented the research. This new test should be a welcome addition to our means of detecting neuropathy, identifying patients at risk for foot ulcers and amputations, as well as falling and fractures and allow early prevention and intervention to avoid these untoward effects of neuropathy." Abstract.

Suggested Articles

When KLAS Research asked more than 300 healthcare leaders to identify the most disruptive company in healthcare, one tech giant was top of mind.

People are demanding free and secure access to their complete health record now. Upcoming federal data-sharing rules will help make that a reality.

A healthcare nonprofit wants to build a “moonshot factory” to bring data science and precision health to remote villages in the developing world.